Monday, Mar 08, 2021
Focus on the big picture

Eli Lilly's COVID-19 drug gets U.S. authorization

Reuters, 10 Feb 2021
The U.S. Food and Drug Administration authorized emergency use of Eli Lilly’s combination antibody therapy to fight COVID-19 in patients to help cut the risk of hospitalization and death.

#EliLilly #COVID19 #News #COVIDtreatment


Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on:
Follow Reuters on Facebook:
Follow Reuters on Twitter:
Follow Reuters on Instagram:
Related Articles